These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 32762830)

  • 41. Don't Worry, Be Happy: Endocannabinoids and Cannabis at the Intersection of Stress and Reward.
    Volkow ND; Hampson AJ; Baler RD
    Annu Rev Pharmacol Toxicol; 2017 Jan; 57():285-308. PubMed ID: 27618739
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Manipulation of the Endocannabinoid System in Colitis: A Comprehensive Review.
    Leinwand KL; Gerich ME; Hoffenberg EJ; Collins CB
    Inflamm Bowel Dis; 2017 Feb; 23(2):192-199. PubMed ID: 28079617
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The Effect of CB1 Antagonism on Hepatic Oxidative/Nitrosative Stress and Inflammation in Nonalcoholic Fatty Liver Disease.
    Jorgačević B; Vučević D; Samardžić J; Mladenović D; Vesković M; Vukićević D; Ješić R; Radosavljević T
    Curr Med Chem; 2021; 28(1):169-180. PubMed ID: 32124686
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Gastrointestinal Physiology and Function.
    Greenwood-Van Meerveld B; Johnson AC; Grundy D
    Handb Exp Pharmacol; 2017; 239():1-16. PubMed ID: 28176047
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Endocannabinoid System: A Multi-Facet Therapeutic Target.
    Kaur R; Ambwani SR; Singh S
    Curr Clin Pharmacol; 2016; 11(2):110-7. PubMed ID: 27086601
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A patent update on cannabinoid receptor 1 antagonists (2015-2018).
    Amato G; Khan NS; Maitra R
    Expert Opin Ther Pat; 2019 Apr; 29(4):261-269. PubMed ID: 30889997
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cannabinoid receptors in the kidney.
    Hryciw DH; McAinch AJ
    Curr Opin Nephrol Hypertens; 2016 Sep; 25(5):459-64. PubMed ID: 27367912
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cannabinoids: A Guide for Use in the World of Gastrointestinal Disease.
    Unal E; Anderson B; Helber A; Marks JH
    J Clin Gastroenterol; 2020 Oct; 54(9):769-788. PubMed ID: 31789770
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Toward modulation of the endocannabinoid system for treatment of gastrointestinal disease: FAAHster but not "higher".
    Nasser Y; Bashashati M; Andrews CN
    Neurogastroenterol Motil; 2014 Apr; 26(4):447-54. PubMed ID: 24641009
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [The endocannabinoid system as a novel target for the treatment of liver fibrosis].
    Teixeira-Clerc F; Julien B; Grenard P; Tran Van Nhieu J; Deveaux V; Hezode C; Mallat A; Lotersztajn S
    Pathol Biol (Paris); 2008 Feb; 56(1):36-8. PubMed ID: 17412522
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Nutrition, endocannabinoids, and the use of cannabis: An overview for the nutrition clinician.
    Russell L; Condo K; DeFlorville T
    Nutr Clin Pract; 2024 Aug; 39(4):815-823. PubMed ID: 38555505
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The Role of the Cannabinoid System in Pain Control: Basic and Clinical Implications.
    Wolf J; Urits I; Orhurhu V; Peck J; Orhurhu MS; Giacomazzi S; Smoots D; Piermarini C; Manchikanti L; Kaye AD; Kaye RJ; Viswanath O
    Curr Pain Headache Rep; 2020 Jun; 24(7):35. PubMed ID: 32506272
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Stress and the gut: pathophysiology, clinical consequences, diagnostic approach and treatment options.
    Konturek PC; Brzozowski T; Konturek SJ
    J Physiol Pharmacol; 2011 Dec; 62(6):591-9. PubMed ID: 22314561
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cannabis and Cardiovascular Disease.
    Ghosh M; Naderi S
    Curr Atheroscler Rep; 2019 Apr; 21(6):21. PubMed ID: 30980200
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cancer Initiation, Progression and Resistance: Are Phytocannabinoids from
    Nigro E; Formato M; Crescente G; Daniele A
    Molecules; 2021 May; 26(9):. PubMed ID: 34063214
    [No Abstract]   [Full Text] [Related]  

  • 56. Bioactive Chemical Composition of Cannabis Extracts and Cannabinoid Receptors.
    Yang Y; Vyawahare R; Lewis-Bakker M; Clarke HA; Wong AHC; Kotra LP
    Molecules; 2020 Jul; 25(15):. PubMed ID: 32751516
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cannabinoids: Medical implications.
    Schrot RJ; Hubbard JR
    Ann Med; 2016; 48(3):128-41. PubMed ID: 26912385
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Characteristics of the gastrointestinal myoelectrical activity in patients with nonalcoholic fatty liver disease associated with metabolic syndrome].
    Tkachenko EI; Avalueva EB; Ivanov SV; Sitkin SI; Skazyvaeva EV; Lapinskiĭ IV; Pushkina AV; Avramova VM
    Eksp Klin Gastroenterol; 2014; (8):46-53. PubMed ID: 25911912
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Role for endocannabinoids in early pregnancy: recent advances and the effects of cannabis use.
    Ezechukwu HC; Diya CA; Shrestha N; Hryciw DH
    Am J Physiol Endocrinol Metab; 2020 Sep; 319(3):E557-E561. PubMed ID: 32744098
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Modern approaches to the development of synthetic cannabinoid receptor probes.
    Saldaña-Shumaker SL; Grenning AJ; Cunningham CW
    Pharmacol Biochem Behav; 2021 Apr; 203():173119. PubMed ID: 33508249
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.